Sailaja R Bommakanti, MD
Internal Medicine · Campbell
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Office
- 1
Offices
1 location · University Healthcare Alliance · 334 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health · Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bommakanti’s office at (408) 357-1410 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A66780 · Current
Licensed to practise in California · since 1998 · expires 2028-05-31 · Osmania University, Gandhi Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$74,622
Medicare paid this office $74,622 for 305 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 189 | $36,212 | $104 |
| Short return visit (20+ min) | 125 | $13,085 | $77 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 60 | $9,185 | $153 |
| Short return visit | 66 | $3,680 | $49 |
| New patient visit (45+ min) | 27 | $3,386 | $125 |
See all 10 services
| Return visit (30+ min) | 189 | $36,212 | $104 |
| Short return visit (20+ min) | 125 | $13,085 | $77 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 60 | $9,185 | $153 |
| Short return visit | 66 | $3,680 | $49 |
| New patient visit (45+ min) | 27 | $3,386 | $125 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 11 | $3,195 | $290 |
| Influenza vaccine split virus, preservative free | 15 | $1,198 | $80 |
| Administration of influenza virus vaccine | 16 | $612 | $38 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 35 | $538 | $15 |
| Administration of pneumococcal vaccine | 11 | $420 | $38 |
Who their Medicare patients are
305 Original Medicare patients in 2024. Average age 75 · Women 72% · Also on Medicaid 6% · Health risk score 1.07. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 68% · Diabetes 28% · Coronary heart disease 23% · Chronic kidney disease 22% · Cancer 18% · Atrial fibrillation 13% · Depression 13% · Heart failure 11% · COPD 8% · Dementia 7% · Stroke 6%.
The office billed $283,894, Medicare allowed $102,744 and paid $74,622; for 815 services of 20 kinds; $4,414 of it was for drugs given in the office and $70,208 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 305 | 815 | 75 | 1.07 | $283,894 | $74,622 |
| 2023 | 268 | 701 | 75 | 1.05 | $248,151 | $69,018 |
| 2022 | 266 | 717 | 75 | 0.98 | $252,423 | $71,985 |
| 2021 | 230 | 556 | 75 | 1.01 | $211,526 | $57,895 |
| 2020 | 185 | 620 | 75 | 1.00 | $204,831 | $47,494 |
| 2019 | 181 | 551 | 75 | 1.08 | $188,973 | $41,810 |
| 2018 | 188 | 501 | 73 | 1.10 | $174,937 | $40,606 |
| 2017 | 334 | 651 | 75 | 1.08 | $193,749 | $49,732 |
| 2016 | 171 | 440 | 75 | 0.92 | $120,681 | $34,164 |
| 2015 | 224 | 847 | 74 | 1.18 | $214,935 | $69,039 |
| 2014 | 197 | 833 | 74 | 0.96 | $165,626 | $55,028 |
| 2013 | 191 | 802 | 74 | 1.00 | $114,645 | $55,090 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Return visit (30+ min) | 166 | $26,722 | $108 |
| Short return visit (20+ min) | 127 | $13,376 | $76 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 29 | $8,175 | $282 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 48 | $7,483 | $156 |
| New patient visit (45+ min) | 30 | $3,666 | $122 |
| Short return visit | 34 | $1,777 | $49 |
| Influenza vaccine split virus, preservative free | 22 | $1,579 | $72 |
| New patient visit (30+ min) | 16 | $1,490 | $93 |
| Administration of pneumococcal vaccine | 29 | $1,072 | $37 |
| Administration of influenza virus vaccine | 23 | $850 | $37 |
2022: 10 services
| Return visit (30+ min) | 150 | $23,537 | $107 |
| Short return visit (20+ min) | 133 | $15,774 | $79 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 45 | $7,143 | $159 |
| New patient visit (45+ min) | 46 | $5,877 | $128 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 21 | $5,839 | $278 |
| Long return visit (40+ min) | 21 | $3,135 | $149 |
| Influenza vaccine split virus, preservative free | 29 | $1,981 | $68 |
| New patient visit (30+ min) | 20 | $1,923 | $96 |
| Administration of pneumococcal vaccine | 31 | $1,160 | $37 |
| Administration of influenza virus vaccine | 31 | $1,156 | $37 |
2021: 8 services
| Return visit (30+ min) | 137 | $23,892 | $113 |
| Short return visit (20+ min) | 97 | $10,667 | $76 |
| New patient visit (45+ min) | 30 | $5,002 | $167 |
| Long return visit (40+ min) | 23 | $4,795 | $171 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 22 | $3,600 | $164 |
| New patient visit (30+ min) | 29 | $3,176 | $110 |
| Pneumococcal vaccine, 23-valent | 14 | $1,757 | $125 |
| Administration of pneumococcal vaccine | 20 | $441 | $22 |
2020: 9 services
| Return visit (30+ min) | 98 | $14,921 | $94 |
| Short return visit (20+ min) | 110 | $13,552 | $65 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 24 | $3,460 | $144 |
| Telephone medical discussion with physician, 11-20 minutes | 32 | $2,591 | $66 |
| New patient visit (45+ min) | 18 | $2,557 | $142 |
| Influenza vaccine split virus, preservative free | 36 | $2,232 | $60 |
| New patient visit (30+ min) | 16 | $1,352 | $85 |
| Administration of influenza virus vaccine | 37 | $794 | $21 |
| Administration of pneumococcal vaccine | 16 | $333 | $21 |
2019: 9 services
| Short return visit (20+ min) | 112 | $11,636 | $61 |
| Return visit (30+ min) | 90 | $10,753 | $88 |
| New patient visit (45+ min) | 45 | $5,936 | $132 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 30 | $4,251 | $142 |
| Pneumococcal vaccine, 23-valent | 20 | $2,220 | $111 |
| Pneumococcal vaccine, 13-valent | 11 | $2,129 | $194 |
| Influenza vaccine split virus, preservative free | 21 | $1,153 | $55 |
| Administration of pneumococcal vaccine | 30 | $615 | $21 |
| Administration of influenza virus vaccine | 24 | $492 | $21 |
2018: 10 services
| Return visit (30+ min) | 88 | $11,165 | $83 |
| Long return visit (40+ min) | 53 | $7,336 | $103 |
| Short return visit (20+ min) | 79 | $6,627 | $61 |
| New patient visit (45+ min) | 29 | $3,216 | $111 |
| Pneumococcal vaccine, 13-valent | 14 | $2,814 | $201 |
| New patient visit (60+ min) | 16 | $2,355 | $147 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $2,106 | $140 |
| Influenza vaccine split virus, preservative free | 19 | $1,033 | $52 |
| Administration of pneumococcal vaccine | 23 | $592 | $26 |
| Administration of influenza virus vaccine | 20 | $540 | $26 |
2017: 9 services
| Return visit (30+ min) | 169 | $21,397 | $88 |
| Short return visit (20+ min) | 167 | $11,211 | $54 |
| Long return visit (40+ min) | 30 | $4,467 | $131 |
| New patient visit (45+ min) | 31 | $4,105 | $132 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 17 | $2,355 | $139 |
| New patient visit (60+ min) | 12 | $2,283 | $190 |
| Influenza vaccine split virus, preservative free | 18 | $846 | $47 |
| Administration of influenza virus vaccine | 23 | $743 | $32 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 23 | $312 | $14 |
2016: 10 services
| Return visit (30+ min) | 82 | $9,473 | $78 |
| Short return visit (20+ min) | 81 | $5,774 | $59 |
| Pneumococcal vaccine, 13-valent | 26 | $4,439 | $171 |
| Long return visit (40+ min) | 28 | $3,533 | $107 |
| New patient visit (45+ min) | 20 | $2,879 | $144 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | $2,858 | $136 |
| Influenza vaccine split virus, preservative free | 25 | $1,028 | $41 |
| Administration of influenza virus vaccine | 28 | $887 | $32 |
| Administration of pneumococcal vaccine | 26 | $824 | $32 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $227 | $16 |
2015: 9 services
| Return visit (30+ min) | 149 | $21,996 | $88 |
| Short return visit (20+ min) | 119 | $10,113 | $57 |
| Pneumococcal vaccine, 13-valent | 59 | $9,842 | $167 |
| Long return visit (40+ min) | 58 | $9,322 | $139 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 39 | $5,655 | $145 |
| Administration of pneumococcal vaccine | 58 | $1,841 | $32 |
| Administration of influenza virus vaccine | 49 | $1,621 | $32 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 45 | $531 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 17 | $293 | $15 |
2014: 12 services
| Return visit (30+ min) | 125 | $17,002 | $85 |
| Short return visit (20+ min) | 128 | $13,851 | $58 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 57 | $7,683 | $135 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 13 | $2,578 | $198 |
| Long return visit (40+ min) | 18 | $2,418 | $127 |
| New patient visit (45+ min) | 15 | $1,952 | $130 |
| Administration of influenza virus vaccine | 53 | $1,836 | $31 |
| Pneumococcal vaccine, 23-valent | 24 | $1,809 | $75 |
| Administration of pneumococcal vaccine | 24 | $747 | $31 |
| Short return visit | 15 | $607 | $34 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) | 52 | $488 | $8 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 25 | $384 | $15 |
2013: 11 services
| Short return visit (20+ min) | 141 | $18,194 | $60 |
| Return visit (30+ min) | 104 | $13,175 | $81 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 54 | $7,195 | $133 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 21 | $4,167 | $198 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 14 | $2,527 | $97 |
| Long return visit (40+ min) | 12 | $1,668 | $128 |
| Short return visit | 39 | $1,472 | $38 |
| Administration of influenza virus vaccine | 34 | $1,071 | $32 |
| Pneumococcal vaccine, 23-valent | 11 | $740 | $67 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 28 | $425 | $15 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) | 30 | $252 | $8 |
Drugs they prescribed that Part D paid
$100,906
Pharmacies billed $100,906 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (25 of 2,193) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
2,018 generic and fewer than 11 brand-name prescriptions · $100,906 in drug cost · 46 antibiotic prescriptions to 34 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 25 | $37,243 | $1,490 |
| Atorvastatin | 297 | $2,024 | $7 |
| Rosuvastatin | 76 | $1,721 | $23 |
| Levothyroxine | 180 | $1,571 | $9 |
| Synthroid | 19 | $1,446 | $76 |
See all 41 drugs
| Eliquis | 25 | $37,243 | $1,490 |
| Atorvastatin | 297 | $2,024 | $7 |
| Rosuvastatin | 76 | $1,721 | $23 |
| Levothyroxine | 180 | $1,571 | $9 |
| Synthroid | 19 | $1,446 | $76 |
| Losartan | 133 | $1,024 | $8 |
| Albuterol Sulfate Hfa | 36 | $995 | $28 |
| Amlodipine Besylate | 160 | $987 | $6 |
| Olmesartan-Hydrochlorothiazide | 13 | $839 | $65 |
| Lisinopril | 114 | $679 | $6 |
| Pravastatin | 37 | $519 | $14 |
| Celecoxib | 16 | $518 | $32 |
| Metoprolol | 41 | $511 | $12 |
| Benazepril | 35 | $483 | $14 |
| Escitalopram | 17 | $459 | $27 |
| Tamsulosin | 21 | $394 | $19 |
| Gabapentin | 18 | $342 | $19 |
| Simvastatin | 42 | $323 | $8 |
| Allopurinol | 13 | $309 | $24 |
| Omeprazole | 35 | $295 | $8 |
| Chlorthalidone | 16 | $291 | $18 |
| Carvedilol | 11 | $280 | $25 |
| Sumatriptan | 38 | $265 | $7 |
| Ezetimibe | 17 | $264 | $16 |
| Potassium Chloride | 14 | $253 | $18 |
| Atenolol | 26 | $223 | $9 |
| Enalapril Maleate | 15 | $220 | $15 |
| Hydrocodone-Acetaminophen | 15 | $214 | $14 |
| Metformin Hcl Er | 22 | $208 | $9 |
| Metformin | 51 | $200 | $4 |
| Olmesartan Medoxomil | 12 | $173 | $14 |
| Trazodone | 17 | $136 | $8 |
| Losartan-Hydrochlorothiazide | 22 | $124 | $6 |
| Citalopram Hbr | 18 | $119 | $7 |
| Alendronate | 34 | $118 | $3 |
| Furosemide | 15 | $111 | $7 |
| Fluticasone Propionate | 12 | $94 | $8 |
| Hydrochlorothiazide | 21 | $67 | $3 |
| Pantoprazole | 15 | $48 | $3 |
| Alprazolam | 17 | $45 | $3 |
| Metoprolol | 13 | $27 | $2 |
Year by year
| 2024 | 2,193 | 317 | 1% (25) | None | $100,906 |
| 2023 | 2,292 | 321 | 1% (29) | 7% | $91,871 |
| 2022 | 2,094 | 307 | 2% (37) | 9% | $96,671 |
| 2021 | 1,606 | 210 | 2% (29) | None | $80,344 |
| 2020 | 1,547 | 175 | 2% (26) | 12% | $57,144 |
| 2019 | 1,562 | 182 | 2% (23) | None | $49,080 |
| 2018 | 1,372 | 174 | 2% (22) | None | $43,736 |
| 2017 | 1,186 | 206 | 3% (34) | None | $45,596 |
| 2016 | 3,007 | 381 | 1% (28) | 15% | $129,496 |
| 2015 | 4,809 | 416 | 1% (48) | 15% | $186,683 |
| 2014 | 4,911 | 355 | 2% (103) | 17% | $209,032 |
| 2013 | 5,327 | 391 | 2% (124) | 17% | $222,569 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 46 drugs
| Eliquis | 14 | $15,311 | $1,094 |
| Atorvastatin | 294 | $3,023 | $10 |
| Levothyroxine | 184 | $2,481 | $13 |
| Losartan | 150 | $2,102 | $14 |
| Rosuvastatin | 71 | $1,871 | $26 |
| Amlodipine Besylate | 155 | $1,465 | $9 |
| Tamsulosin | 41 | $1,185 | $29 |
| Albuterol Sulfate Hfa | 23 | $1,135 | $49 |
| Synthroid | 12 | $1,121 | $93 |
| Ventolin Hfa | 12 | $990 | $83 |
| Olmesartan-Hydrochlorothiazide | 16 | $958 | $60 |
| Pravastatin | 44 | $927 | $21 |
| Lisinopril | 101 | $812 | $8 |
| Metoprolol | 54 | $735 | $14 |
| Duloxetine | 21 | $640 | $30 |
| Pantoprazole | 40 | $562 | $14 |
| Ezetimibe | 13 | $537 | $41 |
| Celecoxib | 17 | $492 | $29 |
| Losartan-Hydrochlorothiazide | 24 | $485 | $20 |
| Alendronate | 31 | $449 | $14 |
| Fluticasone Propionate | 18 | $382 | $21 |
| Metformin Hcl Er | 29 | $352 | $12 |
| Benazepril | 29 | $324 | $11 |
| Gabapentin | 26 | $316 | $12 |
| Simvastatin | 43 | $302 | $7 |
| Trazodone | 34 | $302 | $9 |
| Allopurinol | 11 | $293 | $27 |
| Atenolol | 21 | $287 | $14 |
| Potassium Chloride | 12 | $276 | $23 |
| Hydrocodone-Acetaminophen | 21 | $263 | $13 |
| Sumatriptan | 23 | $263 | $11 |
| Rizatriptan | 15 | $261 | $17 |
| Omeprazole | 26 | $258 | $10 |
| Chlorthalidone | 18 | $249 | $14 |
| Metformin | 35 | $191 | $5 |
| Enalapril Maleate | 14 | $174 | $12 |
| Finasteride | 13 | $168 | $13 |
| Olmesartan Medoxomil | 11 | $155 | $14 |
| Citalopram Hbr | 14 | $148 | $11 |
| Famotidine | 13 | $123 | $9 |
| Hydrochlorothiazide | 21 | $116 | $6 |
| Furosemide | 21 | $109 | $5 |
| Alprazolam | 22 | $85 | $4 |
| Omega-3 Acid Ethyl Esters | 12 | $82 | $7 |
| Metoprolol | 14 | $69 | $5 |
| Lisinopril-Hydrochlorothiazide | 12 | $48 | $4 |
2022: 45 drugs
| Eliquis | 21 | $20,418 | $972 |
| Belsomra | 12 | $5,006 | $417 |
| Rivastigmine | 11 | $2,294 | $209 |
| Levothyroxine | 150 | $2,078 | $14 |
| Atorvastatin | 235 | $1,871 | $8 |
| Rosuvastatin | 59 | $1,856 | $31 |
| Losartan | 147 | $1,285 | $9 |
| Losartan-Hydrochlorothiazide | 20 | $1,185 | $59 |
| Pravastatin | 58 | $1,079 | $19 |
| Raloxifene | 11 | $1,021 | $93 |
| Rizatriptan | 19 | $804 | $42 |
| Albuterol Sulfate Hfa | 15 | $751 | $50 |
| Metoprolol | 52 | $745 | $14 |
| Duloxetine | 22 | $740 | $34 |
| Amlodipine Besylate | 120 | $698 | $6 |
| Olmesartan-Hydrochlorothiazide | 12 | $668 | $56 |
| Potassium Chloride | 23 | $604 | $26 |
| Celecoxib | 13 | $584 | $45 |
| Tamsulosin | 21 | $481 | $23 |
| Simvastatin | 42 | $383 | $9 |
| Pantoprazole | 37 | $382 | $10 |
| Hydrocodone-Acetaminophen | 17 | $336 | $20 |
| Chlorthalidone | 17 | $322 | $19 |
| Lisinopril | 78 | $321 | $4 |
| Alendronate | 20 | $307 | $15 |
| Metformin Hcl Er | 25 | $307 | $12 |
| Gabapentin | 17 | $286 | $17 |
| Liothyronine | 12 | $271 | $23 |
| Trazodone | 37 | $269 | $7 |
| Metformin | 47 | $256 | $5 |
| Omeprazole | 14 | $231 | $17 |
| Fluticasone Propionate | 19 | $226 | $12 |
| Donepezil | 13 | $197 | $15 |
| Famotidine | 13 | $174 | $13 |
| Nitrofurantoin Mono-Macro | 12 | $172 | $14 |
| Sumatriptan | 23 | $166 | $7 |
| Atenolol | 13 | $161 | $12 |
| Buspirone | 13 | $113 | $9 |
| Furosemide | 25 | $105 | $4 |
| Tramadol | 18 | $89 | $5 |
| Zolpidem | 15 | $87 | $6 |
| Alprazolam | 20 | $85 | $4 |
| Hydrochlorothiazide | 21 | $82 | $4 |
| Glipizide | 11 | $52 | $5 |
| Metoprolol | 14 | $45 | $3 |
2021: 34 drugs
| Belsomra | 12 | $4,903 | $409 |
| Levothyroxine | 120 | $2,249 | $19 |
| Atorvastatin | 166 | $1,791 | $11 |
| Rosuvastatin | 31 | $1,489 | $48 |
| Pravastatin | 59 | $1,280 | $22 |
| Losartan | 97 | $1,190 | $12 |
| Duloxetine | 25 | $978 | $39 |
| Losartan-Hydrochlorothiazide | 18 | $785 | $44 |
| Amlodipine Besylate | 107 | $711 | $7 |
| Albuterol Sulfate Hfa | 16 | $659 | $41 |
| Lisinopril | 64 | $492 | $8 |
| Metoprolol | 34 | $470 | $14 |
| Trazodone | 33 | $431 | $13 |
| Simvastatin | 36 | $354 | $10 |
| Hydrocodone-Acetaminophen | 13 | $342 | $26 |
| Gabapentin | 12 | $294 | $25 |
| Escitalopram | 15 | $274 | $18 |
| Raloxifene | 13 | $251 | $19 |
| Benazepril | 13 | $239 | $18 |
| Pantoprazole | 16 | $196 | $12 |
| Estradiol | 11 | $182 | $17 |
| Metformin | 32 | $176 | $5 |
| Atenolol | 11 | $156 | $14 |
| Alendronate | 22 | $152 | $7 |
| Fluticasone Propionate | 17 | $143 | $8 |
| Hydrochlorothiazide | 27 | $132 | $5 |
| Clonidine | 12 | $121 | $10 |
| Rizatriptan | 12 | $109 | $9 |
| Sumatriptan | 15 | $102 | $7 |
| Glimepiride | 16 | $98 | $6 |
| Tramadol | 15 | $92 | $6 |
| Alprazolam | 27 | $92 | $3 |
| Furosemide | 20 | $76 | $4 |
| Glipizide | 14 | $50 | $4 |
2020: 34 drugs
| Shingrix | 21 | $3,799 | $181 |
| Levothyroxine | 108 | $2,507 | $23 |
| Rosuvastatin | 27 | $1,753 | $65 |
| Atorvastatin | 117 | $1,677 | $14 |
| Losartan | 97 | $1,386 | $14 |
| Losartan-Hydrochlorothiazide | 12 | $1,326 | $110 |
| Pravastatin | 45 | $1,151 | $26 |
| Metoprolol | 41 | $1,035 | $25 |
| Synthroid | 12 | $838 | $70 |
| Amlodipine Besylate | 109 | $755 | $7 |
| Trazodone | 36 | $480 | $13 |
| Lisinopril | 62 | $469 | $8 |
| Fluticasone Propionate | 41 | $456 | $11 |
| Duloxetine | 18 | $425 | $24 |
| Simvastatin | 40 | $383 | $10 |
| Rizatriptan | 12 | $371 | $31 |
| Chlorthalidone | 12 | $363 | $30 |
| Hydrochlorothiazide | 44 | $332 | $8 |
| Atenolol | 13 | $297 | $23 |
| Hydrocodone-Acetaminophen | 15 | $296 | $20 |
| Pantoprazole | 11 | $292 | $27 |
| Metformin | 43 | $286 | $7 |
| Gabapentin | 13 | $246 | $19 |
| Tamsulosin | 14 | $231 | $17 |
| Raloxifene | 12 | $222 | $18 |
| Donepezil | 14 | $192 | $14 |
| Fluoxetine | 35 | $177 | $5 |
| Escitalopram | 13 | $156 | $12 |
| Furosemide | 19 | $145 | $8 |
| Ramipril | 15 | $107 | $7 |
| Sumatriptan | 11 | $106 | $10 |
| Tramadol | 11 | $89 | $8 |
| Alprazolam | 21 | $64 | $3 |
| Citalopram Hbr | 15 | $46 | $3 |
2019: 41 drugs
| Bystolic | 13 | $2,891 | $222 |
| Levothyroxine | 99 | $2,194 | $22 |
| Rosuvastatin | 42 | $1,798 | $43 |
| Atorvastatin | 104 | $1,478 | $14 |
| Metoprolol | 43 | $1,294 | $30 |
| Pravastatin | 50 | $1,013 | $20 |
| Pantoprazole | 17 | $887 | $52 |
| Losartan | 70 | $850 | $12 |
| Amlodipine Besylate | 84 | $737 | $9 |
| Duloxetine | 14 | $710 | $51 |
| Bupropion Xl | 12 | $642 | $54 |
| Lisinopril | 63 | $563 | $9 |
| Sertraline | 23 | $533 | $23 |
| Potassium Chloride | 21 | $512 | $24 |
| Metformin | 46 | $510 | $11 |
| Gabapentin | 27 | $497 | $18 |
| Simvastatin | 45 | $389 | $9 |
| Atenolol | 25 | $363 | $15 |
| Hydrocodone-Acetaminophen | 22 | $349 | $16 |
| Omeprazole | 24 | $324 | $13 |
| Donepezil | 14 | $322 | $23 |
| Raloxifene | 12 | $320 | $27 |
| Fluticasone Propionate | 27 | $316 | $12 |
| Valsartan | 11 | $281 | $26 |
| Escitalopram | 18 | $277 | $15 |
| Furosemide | 27 | $255 | $9 |
| Tamsulosin | 17 | $245 | $14 |
| Trazodone | 24 | $231 | $10 |
| Ranitidine | 12 | $217 | $18 |
| Bupropion Hcl Sr | 11 | $203 | $18 |
| Citalopram Hbr | 21 | $176 | $8 |
| Fluoxetine | 20 | $155 | $8 |
| Paroxetine | 16 | $155 | $10 |
| Hydrochlorothiazide | 26 | $149 | $6 |
| Ramipril | 13 | $138 | $11 |
| Lovastatin | 11 | $108 | $10 |
| Alprazolam | 27 | $95 | $4 |
| Zolpidem | 17 | $91 | $5 |
| Lisinopril-Hydrochlorothiazide | 11 | $68 | $6 |
| Glipizide | 12 | $66 | $5 |
| Lorazepam | 16 | $56 | $4 |
2018: 32 drugs
| Levothyroxine | 96 | $2,106 | $22 |
| Celecoxib | 12 | $1,651 | $138 |
| Atorvastatin | 96 | $1,413 | $15 |
| Rosuvastatin | 22 | $1,267 | $58 |
| Pravastatin | 44 | $1,052 | $24 |
| Ventolin Hfa | 16 | $979 | $61 |
| Amlodipine Besylate | 84 | $731 | $9 |
| Metoprolol | 21 | $718 | $34 |
| Pantoprazole | 19 | $674 | $35 |
| Gabapentin | 41 | $646 | $16 |
| Metformin | 58 | $578 | $10 |
| Sertraline | 22 | $576 | $26 |
| Lisinopril | 63 | $563 | $9 |
| Clopidogrel | 11 | $554 | $50 |
| Losartan | 39 | $517 | $13 |
| Hydrocodone-Acetaminophen | 19 | $487 | $26 |
| Simvastatin | 57 | $486 | $9 |
| Valsartan | 17 | $461 | $27 |
| Trazodone | 36 | $373 | $10 |
| Ranitidine | 25 | $371 | $15 |
| Raloxifene | 12 | $354 | $29 |
| Fosinopril | 12 | $325 | $27 |
| Omeprazole | 30 | $321 | $11 |
| Potassium Chloride | 17 | $309 | $18 |
| Atenolol | 30 | $289 | $10 |
| Tamsulosin | 13 | $281 | $22 |
| Furosemide | 26 | $206 | $8 |
| Fluticasone Propionate | 23 | $163 | $7 |
| Paroxetine | 14 | $147 | $11 |
| Hydrochlorothiazide | 23 | $139 | $6 |
| Alprazolam | 20 | $79 | $4 |
| Glipizide | 14 | $68 | $5 |
2017: 33 drugs
| Spiriva | 14 | $5,109 | $365 |
| Levothyroxine | 87 | $2,349 | $27 |
| Celecoxib | 12 | $1,559 | $130 |
| Atorvastatin | 80 | $1,092 | $14 |
| Rosuvastatin | 17 | $888 | $52 |
| Proair Hfa | 14 | $798 | $57 |
| Hydrocodone-Acetaminophen | 25 | $641 | $26 |
| Lisinopril | 68 | $625 | $9 |
| Metoprolol | 12 | $495 | $41 |
| Metformin | 53 | $470 | $9 |
| Simvastatin | 54 | $446 | $8 |
| Losartan | 35 | $414 | $12 |
| Potassium Chloride | 12 | $411 | $34 |
| Pravastatin | 17 | $387 | $23 |
| Atenolol | 41 | $354 | $9 |
| Fluticasone Propionate | 17 | $324 | $19 |
| Amlodipine Besylate | 50 | $279 | $6 |
| Clopidogrel | 13 | $250 | $19 |
| Tizanidine | 12 | $248 | $21 |
| Omeprazole | 20 | $243 | $12 |
| Pantoprazole | 14 | $222 | $16 |
| Hydrochlorothiazide | 30 | $217 | $7 |
| Fluoxetine | 17 | $192 | $11 |
| Ranitidine | 15 | $174 | $12 |
| Fosinopril | 11 | $159 | $14 |
| Trazodone | 13 | $137 | $11 |
| Furosemide | 21 | $128 | $6 |
| Glipizide | 17 | $100 | $6 |
| Amoxicillin | 16 | $88 | $6 |
| Carvedilol | 11 | $86 | $8 |
| Ciprofloxacin | 14 | $82 | $6 |
| Ramipril | 12 | $80 | $7 |
| Alprazolam | 13 | $67 | $5 |
2016: 55 drugs
| Spiriva | 45 | $16,986 | $377 |
| Lantus Solostar | 15 | $8,070 | $538 |
| Vesicare | 13 | $4,839 | $372 |
| Benicar | 17 | $4,508 | $265 |
| Advair Diskus | 13 | $4,442 | $342 |
| Atrovent Hfa | 14 | $4,250 | $304 |
| Levothyroxine | 125 | $3,500 | $28 |
| Proair Hfa | 50 | $3,183 | $64 |
| Atorvastatin | 116 | $2,308 | $20 |
| Lisinopril | 152 | $1,758 | $12 |
| Pravastatin | 69 | $1,674 | $24 |
| Synthroid | 28 | $1,522 | $54 |
| Simvastatin | 135 | $1,359 | $10 |
| Losartan | 115 | $1,268 | $11 |
| Valsartan | 17 | $1,242 | $73 |
| Omeprazole | 88 | $1,236 | $14 |
| Gabapentin | 78 | $1,193 | $15 |
| Amlodipine Besylate | 144 | $1,158 | $8 |
| Metformin | 124 | $1,116 | $9 |
| Oxybutynin Chloride | 24 | $1,055 | $44 |
| Nifedipine Er | 19 | $1,033 | $54 |
| Warfarin | 77 | $1,001 | $13 |
| Lovastatin | 69 | $955 | $14 |
| Clopidogrel | 42 | $929 | $22 |
| Benazepril | 67 | $741 | $11 |
| Fluoxetine | 25 | $691 | $28 |
| Pantoprazole | 46 | $655 | $14 |
| Metoprolol | 29 | $626 | $22 |
| Atenolol | 96 | $613 | $6 |
| Diltiazem 24hr Er | 14 | $586 | $42 |
| Furosemide | 72 | $570 | $8 |
| Potassium Chloride | 15 | $570 | $38 |
| Alendronate | 49 | $475 | $10 |
| Metoprolol | 65 | $465 | $7 |
| Bupropion Xl | 14 | $447 | $32 |
| Glimepiride | 28 | $425 | $15 |
| Hydrocodone-Acetaminophen | 21 | $419 | $20 |
| Hydrochlorothiazide | 64 | $412 | $6 |
| Citalopram Hbr | 17 | $410 | $24 |
| Ranitidine | 42 | $407 | $10 |
| Insulin | 13 | $393 | $30 |
| Fluticasone Propionate | 27 | $374 | $14 |
| Escitalopram | 21 | $369 | $18 |
| Carvedilol | 22 | $314 | $14 |
| Tamsulosin | 20 | $299 | $15 |
| Isosorbide Mononitrate Er | 11 | $256 | $23 |
| Sertraline | 24 | $233 | $10 |
| Metformin Hcl Er | 12 | $226 | $19 |
| Enalapril Maleate | 11 | $223 | $20 |
| Ramipril | 13 | $209 | $16 |
| Glipizide | 20 | $166 | $8 |
| Sumatriptan | 12 | $140 | $12 |
| Hydralazine | 17 | $124 | $7 |
| Azithromycin | 14 | $109 | $8 |
| Alprazolam | 20 | $79 | $4 |
2015: 81 drugs
| Spiriva | 41 | $14,064 | $343 |
| Lantus | 19 | $10,182 | $536 |
| Atrovent Hfa | 31 | $8,296 | $268 |
| Lantus Solostar | 12 | $7,934 | $661 |
| Advair Diskus | 18 | $5,628 | $313 |
| Flovent Hfa | 19 | $5,548 | $292 |
| Levothyroxine | 220 | $5,327 | $24 |
| Levemir | 14 | $3,696 | $264 |
| Benicar | 12 | $3,415 | $285 |
| Valsartan | 34 | $3,390 | $100 |
| Atorvastatin | 195 | $3,128 | $16 |
| Lidocaine | 13 | $3,012 | $232 |
| Proair Hfa | 46 | $2,878 | $63 |
| Lanoxin | 12 | $2,465 | $205 |
| Simvastatin | 262 | $2,447 | $9 |
| Lisinopril | 242 | $2,323 | $10 |
| Pravastatin | 78 | $2,270 | $29 |
| Omeprazole | 160 | $1,934 | $12 |
| Amlodipine Besylate | 251 | $1,785 | $7 |
| Warfarin | 105 | $1,763 | $17 |
| Lovastatin | 125 | $1,744 | $14 |
| Novolin N | 14 | $1,625 | $116 |
| Nifedipine Er | 32 | $1,624 | $51 |
| Metformin | 172 | $1,554 | $9 |
| Oxybutynin Chloride | 43 | $1,540 | $36 |
| Losartan | 141 | $1,472 | $10 |
| Synthroid | 34 | $1,432 | $42 |
| Gabapentin | 83 | $1,401 | $17 |
| Potassium Chloride | 30 | $1,367 | $46 |
| Bupropion Xl | 38 | $1,213 | $32 |
| Omega-3 Acid Ethyl Esters | 12 | $1,209 | $101 |
| Hydrocodone-Acetaminophen | 39 | $1,089 | $28 |
| Captopril | 14 | $1,083 | $77 |
| Fluoxetine | 38 | $999 | $26 |
| Furosemide | 137 | $997 | $7 |
| Pantoprazole | 71 | $997 | $14 |
| Atenolol | 150 | $956 | $6 |
| Benazepril | 85 | $952 | $11 |
| Metoprolol | 94 | $938 | $10 |
| Clopidogrel | 43 | $919 | $21 |
| Alendronate | 68 | $829 | $12 |
| Oxybutynin Chloride Er | 14 | $777 | $55 |
| Benazepril-Hydrochlorothiazide | 12 | $697 | $58 |
| Ranitidine | 67 | $695 | $10 |
| Hydrochlorothiazide | 95 | $662 | $7 |
| Sertraline | 84 | $637 | $8 |
| Fosinopril | 21 | $591 | $28 |
| Bd Ultra-Fine Pen Needle | 11 | $579 | $53 |
| Pramipexole Dihydrochloride | 11 | $551 | $50 |
| Diltiazem Er | 13 | $550 | $42 |
| Voltaren | 11 | $550 | $50 |
| Escitalopram | 37 | $451 | $12 |
| Glipizide | 63 | $440 | $7 |
| Enalapril Maleate | 14 | $426 | $30 |
| Valsartan-Hydrochlorothiazide | 12 | $420 | $35 |
| Triamterene-Hydrochlorothiazid | 36 | $418 | $12 |
| Fluticasone Propionate | 24 | $355 | $15 |
| Imipramine | 12 | $345 | $29 |
| Digox | 12 | $341 | $28 |
| Metoprolol | 12 | $327 | $27 |
| Metformin Hcl Er | 21 | $326 | $16 |
| Carvedilol | 37 | $309 | $8 |
| Amitriptyline | 19 | $292 | $15 |
| Isosorbide Mononitrate Er | 12 | $278 | $23 |
| Azithromycin | 37 | $270 | $7 |
| Trazodone | 33 | $266 | $8 |
| Citalopram Hbr | 28 | $263 | $9 |
| Glimepiride | 19 | $235 | $12 |
| Zolpidem | 19 | $229 | $12 |
| Losartan-Hydrochlorothiazide | 19 | $210 | $11 |
| Gemfibrozil | 15 | $206 | $14 |
| Allopurinol | 16 | $202 | $13 |
| Hydralazine | 19 | $199 | $10 |
| Paroxetine | 13 | $186 | $14 |
| Sumatriptan | 13 | $180 | $14 |
| Meclizine | 11 | $144 | $13 |
| Ciprofloxacin | 31 | $142 | $5 |
| Alprazolam | 47 | $139 | $3 |
| Lisinopril-Hydrochlorothiazide | 13 | $109 | $8 |
| Estradiol | 15 | $59 | $4 |
| Diazepam | 18 | $45 | $2 |
2014: 89 drugs
| Spiriva | 39 | $15,235 | $391 |
| Lantus | 20 | $14,133 | $707 |
| Lantus Solostar | 18 | $11,340 | $630 |
| Diovan | 30 | $9,790 | $326 |
| Atrovent Hfa | 30 | $7,455 | $248 |
| Advair Diskus | 17 | $7,234 | $426 |
| Actonel | 12 | $5,680 | $473 |
| Levothyroxine | 262 | $5,096 | $19 |
| Crestor | 14 | $4,425 | $316 |
| Atorvastatin | 182 | $4,364 | $24 |
| Flovent Hfa | 17 | $4,095 | $241 |
| Proair Hfa | 53 | $3,207 | $61 |
| Symbicort | 11 | $2,918 | $265 |
| Lisinopril | 248 | $2,899 | $12 |
| Simvastatin | 245 | $2,728 | $11 |
| Valsartan | 11 | $2,689 | $244 |
| Omeprazole | 172 | $2,282 | $13 |
| Nifedipine Er | 33 | $2,125 | $64 |
| Lovastatin | 148 | $2,062 | $14 |
| Hydrocodone-Acetaminophen | 66 | $1,982 | $30 |
| Qvar | 11 | $1,959 | $178 |
| Metformin | 142 | $1,889 | $13 |
| Potassium Chloride | 45 | $1,874 | $42 |
| Pravastatin | 62 | $1,867 | $30 |
| Amlodipine Besylate | 205 | $1,562 | $8 |
| Alendronate | 142 | $1,537 | $11 |
| Losartan | 118 | $1,477 | $13 |
| Oxybutynin Chloride | 42 | $1,411 | $34 |
| Gabapentin | 74 | $1,296 | $18 |
| Novolin N | 13 | $1,271 | $98 |
| Warfarin | 97 | $1,188 | $12 |
| Vicodin | 14 | $1,186 | $85 |
| Diltiazem Er | 31 | $1,139 | $37 |
| Atenolol | 155 | $1,136 | $7 |
| Oxybutynin Chloride Er | 14 | $1,080 | $77 |
| Fluoxetine | 38 | $1,065 | $28 |
| Synthroid | 26 | $1,052 | $40 |
| Clopidogrel | 50 | $956 | $19 |
| Furosemide | 149 | $947 | $6 |
| Benazepril | 63 | $932 | $15 |
| Hydrochlorothiazide | 115 | $930 | $8 |
| Fenofibrate | 16 | $924 | $58 |
| Pramipexole Dihydrochloride | 24 | $905 | $38 |
| Lanoxin | 12 | $899 | $75 |
| Insulin | 18 | $815 | $45 |
| Metoprolol | 80 | $770 | $10 |
| Diltiazem 24hr Er | 12 | $757 | $63 |
| Pantoprazole | 56 | $750 | $13 |
| Benazepril-Hydrochlorothiazide | 17 | $738 | $43 |
| Venlafaxine Hcl Er | 17 | $728 | $43 |
| Digox | 18 | $710 | $39 |
| Captopril | 13 | $704 | $54 |
| Glipizide | 75 | $652 | $9 |
| Econazole Nitrate | 14 | $639 | $46 |
| Fosinopril | 22 | $636 | $29 |
| Ranitidine | 62 | $632 | $10 |
| Bd Ultra-Fine Pen Needle | 12 | $620 | $52 |
| Montelukast | 18 | $603 | $34 |
| Sertraline | 61 | $570 | $9 |
| Valsartan-Hydrochlorothiazide | 16 | $547 | $34 |
| Triamterene-Hydrochlorothiazid | 44 | $541 | $12 |
| Hydroxychloroquine Sulfate | 15 | $501 | $33 |
| Gemfibrozil | 30 | $487 | $16 |
| Doxazosin Mesylate | 16 | $479 | $30 |
| Metoprolol | 12 | $471 | $39 |
| Carvedilol | 36 | $433 | $12 |
| Fluticasone Propionate | 19 | $393 | $21 |
| Imipramine | 12 | $344 | $29 |
| Fludrocortisone Acetate | 11 | $322 | $29 |
| Zolpidem | 50 | $302 | $6 |
| Metformin Hcl Er | 13 | $302 | $23 |
| Escitalopram | 16 | $298 | $19 |
| Isosorbide Mononitrate Er | 14 | $260 | $19 |
| Tamsulosin | 19 | $250 | $13 |
| Allopurinol | 37 | $210 | $6 |
| Trazodone | 28 | $201 | $7 |
| Azithromycin | 24 | $187 | $8 |
| Clonidine | 16 | $178 | $11 |
| Hydralazine | 16 | $178 | $11 |
| Lisinopril-Hydrochlorothiazide | 11 | $173 | $16 |
| Ciprofloxacin | 26 | $144 | $6 |
| Alprazolam | 42 | $143 | $3 |
| Citalopram Hbr | 15 | $136 | $9 |
| Paroxetine | 11 | $127 | $12 |
| Ibuprofen | 17 | $124 | $7 |
| Amitriptyline | 23 | $123 | $5 |
| Glimepiride | 17 | $105 | $6 |
| Tramadol | 13 | $78 | $6 |
| Diazepam | 16 | $42 | $3 |
2013: 88 drugs
| Diovan | 77 | $20,083 | $261 |
| Spiriva | 42 | $13,330 | $317 |
| Lantus Solostar | 30 | $13,070 | $436 |
| Advair Diskus | 33 | $11,448 | $347 |
| Aciphex | 11 | $8,584 | $780 |
| Lantus | 26 | $8,394 | $323 |
| Actonel | 27 | $8,021 | $297 |
| Atorvastatin | 146 | $6,285 | $43 |
| Namenda | 11 | $4,992 | $454 |
| Atrovent Hfa | 18 | $4,126 | $229 |
| Flovent Hfa | 13 | $4,076 | $314 |
| Simvastatin | 304 | $3,642 | $12 |
| Crestor | 21 | $3,621 | $172 |
| Lisinopril | 320 | $3,525 | $11 |
| Omeprazole | 191 | $3,367 | $18 |
| Levothyroxine | 252 | $3,207 | $13 |
| Nifedipine Er | 37 | $2,785 | $75 |
| Proair Hfa | 50 | $2,511 | $50 |
| Lovastatin | 140 | $2,397 | $17 |
| Amlodipine Besylate | 253 | $2,389 | $9 |
| Diltiazem Er | 40 | $2,374 | $59 |
| Qvar | 15 | $2,360 | $157 |
| Gabapentin | 69 | $2,279 | $33 |
| Metformin | 180 | $2,231 | $12 |
| Valsartan-Hydrochlorothiazide | 25 | $1,923 | $77 |
| Clopidogrel | 57 | $1,601 | $28 |
| Potassium Chloride | 36 | $1,459 | $41 |
| Glipizide | 115 | $1,454 | $13 |
| Losartan | 109 | $1,452 | $13 |
| Metoprolol | 31 | $1,374 | $44 |
| Alendronate | 130 | $1,356 | $10 |
| Atenolol | 156 | $1,312 | $8 |
| Hydrochlorothiazide | 158 | $1,220 | $8 |
| Furosemide | 167 | $1,171 | $7 |
| Benazepril | 78 | $1,165 | $15 |
| Oxybutynin Chloride Er | 15 | $1,093 | $73 |
| Fluoxetine | 62 | $1,069 | $17 |
| Fluticasone Propionate | 38 | $1,058 | $28 |
| Pravastatin | 44 | $1,052 | $24 |
| Hydrocodone-Acetaminophen | 96 | $1,015 | $11 |
| Oxybutynin Chloride | 38 | $985 | $26 |
| Novolin N | 12 | $968 | $81 |
| Diltiazem 24hr Er | 22 | $958 | $44 |
| Metoprolol | 95 | $942 | $10 |
| Warfarin | 79 | $936 | $12 |
| Pantoprazole | 42 | $785 | $19 |
| Venlafaxine Hcl Er | 15 | $751 | $50 |
| Escitalopram | 27 | $745 | $28 |
| Fenofibrate | 11 | $732 | $67 |
| Bd Ultra-Fine Pen Needle | 15 | $695 | $46 |
| Ranitidine | 63 | $673 | $11 |
| Proventil Hfa | 11 | $608 | $55 |
| Benazepril-Hydrochlorothiazide | 19 | $596 | $31 |
| Pramipexole Dihydrochloride | 15 | $582 | $39 |
| Synthroid | 19 | $578 | $30 |
| Sertraline | 41 | $552 | $13 |
| Triamterene-Hctz | 33 | $547 | $17 |
| Montelukast | 15 | $525 | $35 |
| Doxazosin Mesylate | 27 | $490 | $18 |
| Isosorbide Mononitrate Er | 22 | $490 | $22 |
| Fosinopril | 12 | $477 | $40 |
| Nystop | 13 | $471 | $36 |
| Gemfibrozil | 27 | $438 | $16 |
| Insulin | 15 | $434 | $29 |
| Donepezil | 17 | $378 | $22 |
| Imipramine | 11 | $321 | $29 |
| Captopril | 17 | $310 | $18 |
| Carvedilol | 20 | $288 | $14 |
| Lisinopril-Hydrochlorothiazide | 22 | $286 | $13 |
| Zolpidem | 61 | $281 | $5 |
| Metformin Hcl Er | 13 | $273 | $21 |
| Azithromycin | 26 | $264 | $10 |
| Citalopram Hbr | 24 | $221 | $9 |
| Paroxetine | 18 | $202 | $11 |
| Allopurinol | 42 | $200 | $5 |
| Clonidine | 18 | $181 | $10 |
| Alprazolam | 40 | $179 | $4 |
| Ibuprofen | 26 | $176 | $7 |
| Hydroxychloroquine Sulfate | 13 | $170 | $13 |
| Trazodone | 19 | $151 | $8 |
| Hydralazine | 11 | $147 | $13 |
| Tamsulosin | 11 | $144 | $13 |
| Losartan-Hydrochlorothiazide | 11 | $131 | $12 |
| Tramadol | 18 | $127 | $7 |
| Amitriptyline | 30 | $120 | $4 |
| Ciprofloxacin | 21 | $115 | $5 |
| Glimepiride | 17 | $102 | $6 |
| Mirtazapine | 11 | $58 | $5 |
Professional record
- NPI
- 1194828285
- Licence
- CA A66780California A66780: Current · expires 2028-05-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A667800
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 50 E Hamilton Ave Ste 120, Campbell, CA, 95008
- NPI first listed
- 2006-09-06
- NPI last updated
- 2024-04-17
- NPI record certified
- 2024-04-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 625 Lincoln Ave, San Jose, CA, 95126